Tempus AI (NASDAQ:TEM) Shares Down 4.7%

Tempus AI, Inc. (NASDAQ:TEM)’s stock price fell 4.7% during mid-day trading on Tuesday . The company traded as low as $40.44 and last traded at $40.96. 143,726 shares traded hands during trading, a decline of 90% from the average session volume of 1,471,897 shares. The stock had previously closed at $42.98.

Analyst Ratings Changes

A number of brokerages recently issued reports on TEM. Longbow Research began coverage on Tempus AI in a research report on Tuesday, July 9th. They set a “buy” rating and a $48.00 price objective for the company. Morgan Stanley began coverage on Tempus AI in a research report on Tuesday, July 9th. They set an “overweight” rating and a $44.00 price objective for the company. Loop Capital began coverage on Tempus AI in a research report on Tuesday, July 9th. They set a “buy” rating and a $48.00 price objective for the company. William Blair began coverage on Tempus AI in a research report on Tuesday, July 9th. They set an “outperform” rating for the company. Finally, JPMorgan Chase & Co. began coverage on Tempus AI in a research report on Tuesday, July 9th. They set an “overweight” rating and a $42.00 price objective for the company. Nine analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Tempus AI currently has an average rating of “Buy” and an average price target of $45.63.

Tempus AI Price Performance

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.